Genomic Profiling

Compendialogo

Ann Arbor Firm Helps Analyze Lethal, Castration-Resistant Prostate Cancer

A new study by researchers from the University of Michigan, Yale School of Public Health, Brown University and Ann Arbor-based Compendia Bioscience provided a comprehensive genomic profiling of patients with pre-treated lethal metastatic prostate cancer, providing insights into mechanisms of resistance.

WWJ Newsradio 950–05/21/2012

Follow

Get every new post delivered to your Inbox.

Join 1,935 other followers